应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06998 亿腾嘉和
未开盘 02-20 16:08:38
3.180
+0.090
+2.91%
最高
3.250
最低
3.150
成交量
91.45万
今开
3.150
昨收
3.090
日振幅
3.24%
总市值
63.66亿
流通市值
63.66亿
总股本
20.02亿
成交额
292.45万
换手率
0.05%
流通股本
20.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
亿腾嘉和于2月20日斥资4.41万港元回购1.4万股
新浪港股 · 02-22 13:05
亿腾嘉和于2月20日斥资4.41万港元回购1.4万股
亿腾嘉和(6998)回购1.4万股股份,斥资约4.41万港元
公告速递 · 02-20 20:36
亿腾嘉和(6998)回购1.4万股股份,斥资约4.41万港元
亿腾嘉和(06998)2月20日斥资4.41万港元回购1.4万股
智通财经 · 02-20 20:33
亿腾嘉和(06998)2月20日斥资4.41万港元回购1.4万股
亿腾嘉和盘中异动 股价大涨5.18%
市场透视 · 02-20 11:04
亿腾嘉和盘中异动 股价大涨5.18%
亿腾嘉和(06998)更新翌日披露报表,回购2,000股股份,总额约6,160港元
公告速递 · 02-16
亿腾嘉和(06998)更新翌日披露报表,回购2,000股股份,总额约6,160港元
亿腾嘉和(06998)2月16日耗资6160港元回购2000股
智通财经 · 02-16
亿腾嘉和(06998)2月16日耗资6160港元回购2000股
亿腾嘉和医药集团(6998)回购611,500股股份,总额1,858,960港元
公告速递 · 02-13
亿腾嘉和医药集团(6998)回购611,500股股份,总额1,858,960港元
亿腾嘉和(06998)2月13日耗资约185.9万港元回购61.15万股
智通财经 · 02-13
亿腾嘉和(06998)2月13日耗资约185.9万港元回购61.15万股
亿腾嘉和(06998)回购54万股股份,总额约160万港元
公告速递 · 02-12
亿腾嘉和(06998)回购54万股股份,总额约160万港元
亿腾嘉和(06998)2月11日斥资1450港元回购500股
智通财经 · 02-11
亿腾嘉和(06998)2月11日斥资1450港元回购500股
亿腾嘉和医药(06998)回购500股股份,总额约1450港元
公告速递 · 02-11
亿腾嘉和医药(06998)回购500股股份,总额约1450港元
亿腾嘉和医药(6998)回购8,500股股份,总额约2.4万港元
公告速递 · 02-10
亿腾嘉和医药(6998)回购8,500股股份,总额约2.4万港元
港股异动 | 亿腾嘉和(06998)尾盘涨近9% 旗下EDP167临床II期研究成功完成首例受试者给药
智通财经 · 02-10
港股异动 | 亿腾嘉和(06998)尾盘涨近9% 旗下EDP167临床II期研究成功完成首例受试者给药
亿腾嘉和(06998)公布1月股份变动月报 累计回购297.35万股并转为库存
公告速递 · 02-10
亿腾嘉和(06998)公布1月股份变动月报 累计回购297.35万股并转为库存
亿腾嘉和医药集团(06998)回购50.85万股股份,总额约140.85万港元
公告速递 · 02-09
亿腾嘉和医药集团(06998)回购50.85万股股份,总额约140.85万港元
亿腾嘉和(06998)2月9日斥资140.85万港元回购50.85万股
智通财经 · 02-09
亿腾嘉和(06998)2月9日斥资140.85万港元回购50.85万股
亿腾嘉和02月09日主力净流出21.6万元 散户资金买入
市场透视 · 02-09
亿腾嘉和02月09日主力净流出21.6万元 散户资金买入
亿腾嘉和(06998):EDP167 II期临床试验完成首例受试者给药
智通财经 · 02-09
亿腾嘉和(06998):EDP167 II期临床试验完成首例受试者给药
亿腾嘉和(06998.HK)2月6日耗资25万港元回购9.3万股
中金财经 · 02-06
亿腾嘉和(06998.HK)2月6日耗资25万港元回购9.3万股
亿腾嘉和(6998)回购9.3万股股份,总额约25万港元
公告速递 · 02-06
亿腾嘉和(6998)回购9.3万股股份,总额约25万港元
加载更多
公司概况
公司名称:
亿腾嘉和
所属市场:
SEHK
上市日期:
--
主营业务:
亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"亿腾嘉和","latestPrice":3.18,"timestamp":1771574918006,"preClose":3.09,"halted":0,"volume":914500,"delay":0,"changeRate":0.029126213592233108,"floatShares":2002000000,"shares":2002000000,"eps":-0.09986,"marketStatus":"未开盘","change":0.09,"latestTime":"02-20 16:08:38","open":3.15,"high":3.25,"low":3.15,"amount":2924540,"amplitude":0.032362,"askPrice":3.18,"askSize":5500,"bidPrice":3.16,"bidSize":1984500,"shortable":3,"etf":0,"ttmEps":0.016,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":0,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":3.09,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.739446511351559,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2613226291","title":"亿腾嘉和于2月20日斥资4.41万港元回购1.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613226291","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613226291?lang=zh_cn&edition=full","pubTime":"2026-02-22 13:05","pubTimestamp":1771736700,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 亿腾嘉和(06998)发布公告,于2026年2月20日,该公司斥资4.41万港元回购1.4万股股份,每股回购价3.15-3.16港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-22/doc-inhnsisn1036788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"1174035572","title":"亿腾嘉和(6998)回购1.4万股股份,斥资约4.41万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174035572","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174035572?lang=zh_cn&edition=full","pubTime":"2026-02-20 20:36","pubTimestamp":1771590979,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司(06998)于2026年2月20日公告回购股份,共回购14,000股,价格区间介于每股3.15港元至3.16港元,合计支付44,115港元。该笔回购股份被列作公司库藏股。\n\\n\\n回购完成后,公司已发行股本总数维持在2,011,213,774股,流通股数量为2,002,190,774股,库藏股数量增至9,023,000股。公司回购授权于2025年6月26日获通过,剩余可回购股份数量为52,060,469股。公告同时确认,公司已遵守香港联合交易所有限公司证券上市规则及相关法律规定。\n\\n\\n本公告由联席公司秘书翟婧签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2612645052","title":"亿腾嘉和(06998)2月20日斥资4.41万港元回购1.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612645052","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612645052?lang=zh_cn&edition=full","pubTime":"2026-02-20 20:33","pubTimestamp":1771590805,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年2月20日,该公司斥资4.41万港元回购1.4万股股份,每股回购价3.15-3.16港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1583","06998"],"gpt_icon":0},{"id":"2612255770","title":"亿腾嘉和盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612255770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612255770?lang=zh_cn&edition=full","pubTime":"2026-02-20 11:04","pubTimestamp":1771556674,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘11时04分,亿腾嘉和股票出现波动,股价快速拉升5.18%。截至发稿,该股报3.250港元/股,成交量26.1万股,换手率0.01%,振幅3.24%。资金方面,该股资金流入45.378万港元,流出30.1055万港元。亿腾嘉和股票所在的生物技术行业中,整体涨幅为1.39%。其相关个股中,基石药业-B、百奥赛图-B、亿腾嘉和涨幅较大,振幅较大的相关个股有来凯医药-B、基石药业-B、中慧生物-B,振幅分别为9.44%、8.63%、8.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022011043497a68ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022011043497a68ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","06998"],"gpt_icon":0},{"id":"1139183514","title":"亿腾嘉和(06998)更新翌日披露报表,回购2,000股股份,总额约6,160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139183514","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139183514?lang=zh_cn&edition=full","pubTime":"2026-02-16 18:11","pubTimestamp":1771236683,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年2月16日发布翌日披露报表,披露公司于当日回购2,000股普通股股份。每股回购价为每股3.08港元,回购总金额约6,160港元。本次回购股份占此前已发行股份总数的0%。本次交易完成后,公司已发行股份总数仍为2,011,213,774股,其中2,002,204,774股为公众持有股份,9,009,000股为库藏股份。根据公告显示,亿腾嘉和医药集团有限公司于2025年6月26日获得回购授权,可回购最多52,060,469股股份。本次公告由联席公司秘书翟婧签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2611107699","title":"亿腾嘉和(06998)2月16日耗资6160港元回购2000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611107699","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611107699?lang=zh_cn&edition=full","pubTime":"2026-02-16 18:09","pubTimestamp":1771236558,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)公布,2026年2月16日耗资6160港元回购2000股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"1187872801","title":"亿腾嘉和医药集团(6998)回购611,500股股份,总额1,858,960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187872801","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187872801?lang=zh_cn&edition=full","pubTime":"2026-02-13 20:01","pubTimestamp":1770984117,"startTime":"0","endTime":"0","summary":"2026年2月13日,亿腾嘉和医药集团有限公司发布翌日披露报表。公告显示,公司于当日通过香港联合交易所有限公司回购611,500股股份,占回购前已发行股本约0.03%。回购价格为每股3.04港元,总金额1,858,960港元。本次回购后,公司已发行股份总数仍为2,011,213,774股,流通股数变更为2,002,206,774股,库藏股数量增至9,007,000股。截至目前,公司已于交易所累计回购9,007,000股,占授权通过当日已发行股份总数的1.73%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2611744159","title":"亿腾嘉和(06998)2月13日耗资约185.9万港元回购61.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611744159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611744159?lang=zh_cn&edition=full","pubTime":"2026-02-13 19:59","pubTimestamp":1770983997,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)公布,2026年2月13日耗资约185.9万港元回购61.15万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","06998","BK1574"],"gpt_icon":0},{"id":"1139916748","title":"亿腾嘉和(06998)回购54万股股份,总额约160万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139916748","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139916748?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:31","pubTimestamp":1770892260,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年2月12日更新翌日披露报表,公告显示公司当日回购普通股540,000股,占相关事件前已发行股份总数的0.03%。回购价格介乎每股HKD2.95至HKD2.97,合计支付约HKD1,603,130。回购完成后,公司已发行股份数目降至2,002,818,274股,库藏股增至8,395,500股。公司确认已遵守《香港联合交易所有限公司证券上市规则》及相关法律法规。公告由联席公司秘书翟婧签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2610919958","title":"亿腾嘉和(06998)2月11日斥资1450港元回购500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610919958","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610919958?lang=zh_cn&edition=full","pubTime":"2026-02-11 21:36","pubTimestamp":1770816966,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年2月11日斥资1450港元回购500股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"1156500369","title":"亿腾嘉和医药(06998)回购500股股份,总额约1450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156500369","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156500369?lang=zh_cn&edition=full","pubTime":"2026-02-11 21:35","pubTimestamp":1770816955,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司(06998)于2026年2月11日发布翌日披露报表,公告当日于香港联交所场内回购普通股500股,每股回购价为2.9港元,总金额约1450港元。该数量占回购前公司已发行股本的比例极小。\n回购完成后,公司已发行股份数降至2,003,358,274股,库藏股数量增至7,855,500股,总股本继续维持在2,011,213,774股。回购授权决议于2025年6月26日获通过,最高可回购52,060,469股。截至本次回购后,累计已回购7,855,500股。\n公司确认此次股份回购已遵守香港联交所证券上市规则及相关法律法规。公告由联席公司秘书翟婧签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"1126165479","title":"亿腾嘉和医药(6998)回购8,500股股份,总额约2.4万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126165479","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126165479?lang=zh_cn&edition=full","pubTime":"2026-02-10 20:55","pubTimestamp":1770728144,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司(06998)于2026年2月10日发布翌日披露报表,宣布于同日回购8,500股股份,占回购前公司已发行股本约0%。\n此次回购价格区间为每股2.80港元至2.82港元,总耗资约23,960港元。回购完成后,公司已发行股本变动为2,003,358,774股,库藏股数增至7,855,000股。\n公司于2025年6月26日获得股东批准进行股份回购,剩余回购授权额度为52,060,469股。公司并确认已遵守上市规则及相关法律法规。\n本次公告由联席公司秘书翟婧签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2610611709","title":"港股异动 | 亿腾嘉和(06998)尾盘涨近9% 旗下EDP167临床II期研究成功完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2610611709","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610611709?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:26","pubTimestamp":1770708369,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亿腾嘉和尾盘涨近9%,截至发稿,涨6.88%,报2.95港元,成交额350.91万港元。消息面上,2月7日,亿腾嘉和宣布ANGPTL3 siRNA新药EDP167完成二期临床试验首例受试者给药。此次反向收购的达成,标志着亿腾嘉和的正式成立,并在战略整合与发展上迈入全新阶段。嘉和生物-B中文股份简称则由“嘉和生物”更改为“亿腾嘉和”,自2026年2月6日起上午九时正起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583","VT","BK4585","VXUS","BK4588"],"gpt_icon":0},{"id":"1167768974","title":"亿腾嘉和(06998)公布1月股份变动月报 累计回购297.35万股并转为库存","url":"https://stock-news.laohu8.com/highlight/detail?id=1167768974","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167768974?lang=zh_cn&edition=full","pubTime":"2026-02-10 14:40","pubTimestamp":1770705640,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年2月10日发布截至2026年1月31日的股份变动月报。公司注册股本维持3,000,000,000股普通股不变,面值为每股USD 0.00002,注册股本总额仍为USD 60,000。截至2026年1月31日,已发行普通股数量为2,008,240,274股,另有2,973,500股被列作库存股份,总计2,011,213,774股。报告期内,公司于2026年1月28日、1月29日及1月30日分别回购并持作库存股份973,500股、1,000,000股及1,000,000股,合计回购2,973,500股。报告显示,报告期内并无新增发行或注销股份。截至1月底,股本结构整体稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"1125540784","title":"亿腾嘉和医药集团(06998)回购50.85万股股份,总额约140.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125540784","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125540784?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:22","pubTimestamp":1770643375,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年2月9日公告更新翌日披露报表,披露当日通过场内回购股份50.85万股,每股回购价为2.77港元,涉及总金额约140.85万港元。回购完成后,公司已发行股份数量变更为2,003,367,274股,库存股份数目增至7,846,500股。公司购回授权决议通过日期为2025年6月26日,根据该授权可回购股份总数为52,060,469股。公告同时披露,公司确认本次回购活动已遵守香港联合交易所有限公司证券上市规则及相关法律法规的规定。本次公告由联席公司秘书翟婧签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0},{"id":"2610531956","title":"亿腾嘉和(06998)2月9日斥资140.85万港元回购50.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610531956","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610531956?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:20","pubTimestamp":1770643203,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年2月9日,该公司斥资140.85万港元回购50.85万股股份,每股回购价2.77港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和(06998)2月9日斥资140.85万港元回购50.85万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06998","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2610662616","title":"亿腾嘉和02月09日主力净流出21.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2610662616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610662616?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624943,"startTime":"0","endTime":"0","summary":"02月09日, 亿腾嘉和股价跌3.16%,报收2.76元,成交金额615.4万元,换手率0.11%,振幅5.96%,量比0.81。亿腾嘉和今日主力资金净流出21.6万元,上一交易日主力净流入107.5万元。该股近5个交易日上涨10.84%,主力资金累计净流入55.1万元;近20日主力资金累计净流出137.8万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162122a48e47bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162122a48e47bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06998","BK1583"],"gpt_icon":0},{"id":"2610506949","title":"亿腾嘉和(06998):EDP167 II期临床试验完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2610506949","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610506949?lang=zh_cn&edition=full","pubTime":"2026-02-09 08:28","pubTimestamp":1770596919,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,旗下小核酸创新药EDP167 II期临床试验成功完成首例受试者给药。EDP167 II期临床试验是一项针对纯合子家族性高胆固醇血症(HoFH)成人患者的多中心、剂量探索、开放标签的试验,旨在评估EDP167在HoFH患者中的疗效和安全性,其主要终点为首次给药24周后低密度脂蛋白胆固醇(LDL-C)水平相较基线的变化,预计于2026年第四季度完成主要终点的评估。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","06998","BK1574"],"gpt_icon":0},{"id":"2609596848","title":"亿腾嘉和(06998.HK)2月6日耗资25万港元回购9.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596848","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609596848?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:07","pubTimestamp":1770383226,"startTime":"0","endTime":"0","summary":"格隆汇2月6日丨亿腾嘉和(06998.HK)公告,2月6日耗资25万港元回购9.3万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260206/32004697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"1147560946","title":"亿腾嘉和(6998)回购9.3万股股份,总额约25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147560946","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147560946?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:27","pubTimestamp":1770380827,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年2月6日披露翌日披露报表,公告显示公司于当日回购93,000股普通股,成交价介乎每股2.65港元至2.69港元,合计耗资约249,865港元。该回购数量占变动前已发行股份约0.00%。本次回购完成后,亿腾嘉和医药集团有限公司的已发行股份数变为2,003,875,774股,库藏股数增至7,338,000股,总发行股本保持2,011,213,774股。公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":0.3195},{"period":"3month","weight":-0.0245},{"period":"6month","weight":-0.3161},{"period":"1year","weight":0.7667},{"period":"ytd","weight":0.06}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.069875},{"month":2,"riseRate":0.5,"avgChangeRate":0.041452},{"month":3,"riseRate":0.6,"avgChangeRate":0.024884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.110106},{"month":5,"riseRate":0.6,"avgChangeRate":0.031188},{"month":6,"riseRate":0.6,"avgChangeRate":0.043248},{"month":7,"riseRate":0.4,"avgChangeRate":-0.090168},{"month":8,"riseRate":0.4,"avgChangeRate":0.095631},{"month":9,"riseRate":0.4,"avgChangeRate":-0.083466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.052461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044784}],"exchange":"SEHK","name":"亿腾嘉和","nameEN":"EDDING GENOR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿腾嘉和,06998,亿腾嘉和股票,亿腾嘉和股票老虎,亿腾嘉和股票老虎国际,亿腾嘉和行情,亿腾嘉和股票行情,亿腾嘉和股价,亿腾嘉和股市,亿腾嘉和股票价格,亿腾嘉和股票交易,亿腾嘉和股票购买,亿腾嘉和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}